Healthcare Equipment and Supplies
Company Overview of NxThera, Inc.
NxThera, Inc. develops prostate treatment device. The company was incorporated in 2008 and is based in Maple Grove, Minnesota.
7351 Kirkwood Lane North
Maple Grove, MN 55369
Founded in 2008
Key Executives for NxThera, Inc.
Member of Management Board
Compensation as of Fiscal Year 2014.
NxThera, Inc. Key Developments
NxThera, Inc. Appoints Patrick W. Fabian as Chief Commercial Officer
Nov 18 14
NxThera, Inc. announced Patrick W. Fabian has joined the company as its Chief Commercial Officer. In his new role, Mr. Fabian will lead the development and execution of NxThera's sales, marketing, training and education, and customer service strategies as the company begins preparations to commercialize its Rez m System in the U.S. to treat benign prostatic hyperplasia (BPH) following FDA clearance. Mr. Fabian joins NxThera from Sonitus Medical, where he served as Vice President of Sales and Marketing from 2011 through 2014.
NxThera, Inc. Presents at Emerging Medical Technologies Summit, Nov-12-2014 02:45 PM
Nov 10 14
NxThera, Inc. Presents at Emerging Medical Technologies Summit, Nov-12-2014 02:45 PM. Venue: Sofitel Hotel San Francisco, 223 Twin Dolphin Dr., Redwood City, CA 94065, United States.
NXThera, Inc. Completes Enrollment in Rez m II IDE Clinical Trial Assessing Treatment of Benign Prostatic Hyperplasia
Aug 6 14
NxThera, Inc. announced completion of enrollment in its Rez m II IDE clinical trial for the treatment of benign prostatic hyperplasia (BPH). The trial evaluated use of the Rez m(R) System to treat obstructive prostate tissue by convectively delivering sterile water vapor, or steam, directly into the prostate in a minimally invasive procedure that can be performed in a matter of minutes. This multi-center clinical study enrolled 195 men in the U.S., age 50 or older, who were randomized 2:1 to treatment with the Rez m System versus a control procedure.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries